bioAffinity Technologies, Inc. (BIAFW)

0.70USD +78.98% (+0.31)

Over 1M: +730.4%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

0.2 0.4 0.6
14 Jul 17 Jul 31 Jul 10 Aug 18 Aug 21 Aug 2 Sep

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Operating Income: -526.3K Q3 '21 — Net Income: -1.5M Q4 '21 — Operating Income: -659.8K Q4 '21 — Operating Cash Flow: -652.4K Q4 '21 — Net Income: -5.6M Q1 '22 — Operating Income: -727K Q1 '22 — Operating Cash Flow: -634K Q1 '22 — Net Income: -1.5M Q2 '22 — Operating Income: -684.1K Q2 '22 — Operating Cash Flow: -376.1K Q2 '22 — Net Income: -88.1K Q3 '22 — Operating Income: -976.2K Q3 '22 — Operating Cash Flow: -1.8M Q3 '22 — Net Income: -4.9M Q4 '22 — Operating Income: -1.6M Q4 '22 — Operating Cash Flow: -1.3M Q4 '22 — Net Income: -1.7M Q1 '23 — Operating Income: -1.6M Q1 '23 — Operating Cash Flow: -1.5M Q1 '23 — Free Cash Flow: -1.6M Q1 '23 — Net Income: -1.5M Q2 '23 — Operating Income: -1.8M Q2 '23 — Operating Cash Flow: -1.4M Q2 '23 — Free Cash Flow: -1.4M Q2 '23 — Net Income: -1.7M Q3 '23 — Operating Income: -2.3M Q3 '23 — Operating Cash Flow: -1.5M Q3 '23 — Free Cash Flow: -1.5M Q3 '23 — Net Income: -2.3M Q4 '23 — Operating Income: -2.3M Q4 '23 — Operating Cash Flow: -1.6M Q4 '23 — Net Income: -2.4M Q1 '24 — Operating Income: -1.9M Q1 '24 — Operating Cash Flow: -2.3M Q1 '24 — Free Cash Flow: -2.4M Q1 '24 — Net Income: -2M Q2 '24 — Operating Income: -2.1M Q2 '24 — Operating Cash Flow: -1.5M Q2 '24 — Free Cash Flow: -1.6M Q2 '24 — Net Income: -2.1M Q3 '24 — Operating Income: -2M Q3 '24 — Operating Cash Flow: -1.7M Q3 '24 — Free Cash Flow: -1.7M Q3 '24 — Net Income: -2M Q4 '24 — Operating Income: -2.9M Q4 '24 — Operating Cash Flow: -1.7M Q4 '24 — Free Cash Flow: -1.7M Q4 '24 — Net Income: -3M Q1 '25 — Operating Income: -2.6M Q1 '25 — Operating Cash Flow: -1.6M Q1 '25 — Free Cash Flow: -1.7M Q1 '25 — Net Income: -2.7M Q2 '25 — Operating Income: -2.5M Q2 '25 — Operating Cash Flow: -2.6M Q2 '25 — Free Cash Flow: -2.7M Q2 '25 — Net Income: -4.1M Q3 '25 — Operating Income: -2.3M Q3 '25 — Operating Cash Flow: -2.5M Q3 '25 — Free Cash Flow: -2.5M Q3 '25 — Net Income: -5.1M Q4 '25 — Operating Income: -3.1M Q4 '25 — Operating Cash Flow: -2.6M Q4 '25 — Free Cash Flow: -2.6M Q4 '25 — Net Income: -3.1M Q1 '26 — Operating Income: -3.6M Q1 '26 — Operating Cash Flow: -3.2M Q1 '26 — Free Cash Flow: -3.2M Q1 '26 — Net Income: -3.6M Q2 '26 — Operating Income: -3.3M Q2 '26 — Operating Cash Flow: -3.2M Q2 '26 — Free Cash Flow: -3.3M Q2 '26 — Net Income: -3.4M -4.5M -3M -1.5M 0
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Operating Income Operating Cash Flow Free Cash Flow Net Income

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

1.3
SBC / sales 15.8%
OE margin -211.7%
Oper. margin -209.8%
ROIC -505.1%
Accruals -48.8%
EBITDA margin -202.8%
FCF margin -195.9%
OCF margin -194.3%
Profit margin -257.3%
ROA -199.3%
ROCE -250.7%
ROE -402.9%
Gross margin —
OCF / EBIT —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

5.7
EV/Sales 0.65×
EV/OE -0.31×
P/C 2.3×
P/B 1.5×
FCF yield -203.8%
Div. yield —
EV/EBIT —
EV/GP —
Fwd P/E —
P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.1
RPO / sales 0.0053×
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

4.5
ND/EBITDA 0.48
Interest cover -276.1×
Cash / Debt 4.1×
Debt / Eq 0.16×
Debt payback 0.0 yr
Quick ratio 1.4×
Cash runway 0.16 yr
F-score 3.9 pts
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

4.0
Sales/sh Y/Y -82.0%
Sales Q/Q +19.0%
Shares change +326.3%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Sales CAGR 4Y —

3 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.